NAD+ has moved from research settings into IV clinics and, more recently, into at-home injections prescribed by licensed telehealth clinicians. Two things are worth saying up front. First, research into NAD+ supplementation in people is ongoing, and benefits are not established; what follows describes how a prescribed at-home injection works, not what it will do for you. Second, dose and schedule are set by the prescribing clinician and the pharmacy label; this article does not contain them.
With that said, this article walks through how a prescribed at-home NAD+ injection works: what the clinician reviews, where the instructions come from, how sterility is maintained outside a clinical setting, and when to get in-person care.
What NAD+ is, in brief
Nicotinamide adenine dinucleotide is a coenzyme present in every cell. It sits at the center of mitochondrial energy production, DNA-repair signaling through the PARP family, and sirtuin pathways studied in aging research. Supplementing NAD+ is under study; its benefits are not established.
The IV format has dominated the clinic conversation for a decade because it bypasses the gut entirely and delivers a large bolus directly into circulation. The trade-off is well known: an infusion lasting an hour or more, often slowed further by chest pressure, abdominal cramping, or flushing if the rate is pushed. Subcutaneous injection takes a different approach.
Why subcutaneous, not IV, for at-home use
Subcutaneous administration delivers NAD+ into the fat layer beneath the skin, from which it absorbs into circulation over hours rather than minutes. Three practical reasons it is the format used at home:
- Side-effect profile. The flushing and cramping that IV NAD+ can provoke are associated with fast infusion rates. Reported side effects of injected NAD+ include injection-site discomfort, flushing, and nausea.
- Self-administration safety. Subcutaneous injection with an insulin-style needle is the same technique used by millions of insulin-dependent patients. IV access is not a self-administration technique.
- No clinic visit. The injection is given at home, on the schedule your prescriber sets.
Whether either route produces a benefit a person can feel or measure has not been established; the comparison here is about practicality and tolerability, not effectiveness.
Before the first injection
Every at-home NAD+ prescription starts with a licensed clinician reviewing your intake. The review covers three things:
- Eligibility review. Medical history, current medications, prior reactions to injected medications, and any contraindication that would route the patient to in-person care instead. The online visit does not include lab orders or lab review; your clinician may ask you to share recent results you already have.
- Expectations. A frank conversation about the fact that benefits are not established and no result is guaranteed.
- Dose and schedule. Set by your prescriber and printed on the pharmacy label. Not something you choose or adjust.
Your step before the first injection. Read the pharmacy label and your prescriber's directions before you inject. Subcutaneous technique itself (skin preparation, the pinch-and-insert method, depth, angle, and needle disposal) is the same as insulin self-injection. Ask your clinician if anything is unclear.
Who sets the dose and schedule
You will not find dose numbers, weekly totals, or step-up schedules in this article, and you should be wary of any article that gives them. The dose and frequency of subcutaneous NAD+ are set by the prescribing clinician for your individual case and appear on the pharmacy label. Changes (up, down, more often, less often) are also the clinician's decision, usually made at a follow-up after hearing how you have tolerated the injections.
Two things worth knowing so you can report accurately:
- After-injection sensations. Some people describe flushing or a wave of fatigue after an injection. None of these is expected or required; all of them are worth mentioning to your clinician.
- Timing within the day. Follow your prescriber's directions, and tell your clinician about anything you notice.
Sterility outside a clinical setting
Sterility is the part of at-home injection that draws the most concern from new patients. A few routine steps cover it.
What ships from the pharmacy. Compounded NAD+ comes from a licensed US compounding pharmacy, labeled for you with storage instructions and a beyond-use date. Follow the pharmacy's labeled instructions for your vial or syringe.
What each injection needs. A new alcohol prep pad, a new sterile insulin-style needle (unless the syringe is pre-filled), and a sharps container for needle disposal. Sharps containers are available at most pharmacies and via household-hazardous-waste pickup.
What to avoid. No needle reuse. No drawing from a multi-dose vial after the labeled stability window. No injection through clothing. No injection into tissue that is bruised, broken, or showing redness from a prior session.
The basic steps of well-executed at-home subcutaneous injection are the same as those of insulin self-administration.
Following the schedule
Your prescriber sets the days and the dose; the pharmacy label confirms them. A few habits make the schedule easy to follow and the follow-up conversation useful:
- Keep a simple log. Date, time, injection site, and anything you noticed. It is the single most useful thing you can bring to a check-in.
- Injection sites. Follow your clinician's and the pharmacy label's directions on where to inject, so no single area develops repeat irritation.
- Do not skip ahead. If you miss an injection, follow the label and your prescriber's directions; do not double up.
- Check in when told to. Your clinician sets the follow-up cadence. Bring the log.
When to escalate to a clinic
At-home injection is meant for the routine case. It is not designed to substitute for in-person evaluation when something is unusual. Contact your prescribing clinician, or get in-person care locally, if any of the following occur:
- Persistent injection-site reaction. Redness or hardness at a site lasting more than 48 hours, or any sign of infection: warmth, expanding redness, drainage.
- Systemic reaction. Unexplained shortness of breath, chest pain, palpitations, or a rash beyond the injection site. For chest pain or trouble breathing, seek emergency care.
- No change you can point to after the period your clinician set for reassessment. This is a clinical question rather than an emergency, but it is a legitimate reason to ask whether NAD+ is worth continuing: benefits are not established, and "nothing happened" is a real possible outcome.
- A new clinical change unrelated to the medication that the telehealth clinician cannot evaluate at the level needed.
In any of these cases, involving a local primary-care provider is appropriate. At-home injection is not a replacement for in-person care when in-person care is what the situation calls for.
How TelePeptide handles this
NAD+ Injection is available through the TelePep store at $169/month or $507 for 3 months. Care is provided by independent licensed clinicians with Lone Star Virtual Health PLLC through the Bask Health platform. Your payment method is authorized for the plan price at checkout. You are charged only after a licensed clinician prescribes and your order is sent to the pharmacy. If no prescription is issued, the hold is released and you are not charged. It ships from a licensed US compounding pharmacy, typically 2–10 days after your prescription is issued; some orders take longer. NAD+ is available in 48 US states plus the District of Columbia and Puerto Rico, and also in Arkansas and Hawaii. Start your visit.
Prescribing decisions are made solely by licensed clinicians based on individual medical necessity. Compounded medications are not FDA-approved and have not been reviewed by the FDA for safety, effectiveness, or quality.
Editorial note: TelePeptide (the company) is a US direct-pay telehealth brand. Care is provided by independent licensed clinicians with Lone Star Virtual Health PLLC through the Bask Health platform, and the TelePep store offers compounded products including tirzepatide injection (48 US states plus DC and Puerto Rico, not Arkansas or Hawaii), NAD+ injection and sermorelin troche (also available in Arkansas and Hawaii). The brand name is sometimes autocorrected to "telopeptide": an unrelated collagen biomarker; the two terms have no clinical connection.
FAQ
Common questions
Why is subcutaneous NAD+ used at home instead of the IV format clinics offer?
IV NAD+ is a clinic procedure: a slow infusion over an hour or more that can cause flushing, nausea, and chest tightness, particularly at fast infusion rates. A subcutaneous injection is a technique a patient can safely perform at home, using the same basic steps as insulin self-injection. Reported side effects of injected NAD+ include injection-site discomfort, flushing, and nausea. Research into NAD+ supplementation is ongoing and benefits are not established for either route.
How does a patient learn to inject?
The prescribing clinician gives directions on dose and schedule, and the pharmacy label gives preparation and storage instructions; read both before the first injection and ask your clinician if anything is unclear. Subcutaneous injection uses a short, fine insulin-style needle into the abdomen or upper thigh: the technique is comparable to insulin self-injection used by millions of patients daily.
What dose of NAD+ will I be prescribed?
That is decided by the prescribing clinician for your individual case and printed on the pharmacy label. This article does not give dose ranges, schedules, or step-ups, because they are not patient decisions. Never change your dose or frequency on your own; raise any question about it with your clinician.
How is sterility maintained outside a clinical setting?
Follow the pharmacy's labeled instructions for your vial or syringe, including storage and the beyond-use date. Use a fresh alcohol prep pad per injection, a new sterile needle each time, and a sharps container for disposal. Never reuse needles, and never use medication past the date on its label.
When should a patient get in-person care?
Persistent injection-site reactions beyond mild redness, any sign of infection, unexplained shortness of breath, or a clinical change unrelated to the medication all warrant contacting your prescribing clinician. If in-person evaluation is needed, see a local provider; for chest pain or trouble breathing, seek emergency care.
Next Step
Talk to a licensed clinician
A licensed clinician will review your goals and tell you whether a medication on the TelePep store is appropriate. No insurance, no waiting room.
Compounded medications are not FDA-approved and have not been reviewed by the FDA for safety, effectiveness, or quality.
TelePeptide offers direct-pay telehealth services. Independent licensed clinicians with Lone Star Virtual Health PLLC review every intake through the Bask Health platform and decide whether a prescription is appropriate. Prescriptions are filled by licensed US pharmacies; compounded medications are prepared by licensed US compounding pharmacies. Compounded medications are not FDA-approved and have not been reviewed by the FDA for safety, effectiveness, or quality.